Search results
Results From The WOW.Com Content Network
The first Indian biotechnology company to be established was Biocon, which was founded by Kiran Mazumdar-Shaw in 1978. [3] The Indian biotechnology industry formally began in 1986 with the establishment of the Department of Biotechnology (DBT) by the Ministry of Science and Technology. [4]
This page was last edited on 13 February 2023, at 10:45 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Dinamalar Publications Ltd. 17 Sandesh: Gujarati: 5 cities in Gujarat and in Mumbai: 2.884 The Sandesh Ltd. 18 Prabhat Khabar: Hindi: Various cities in Jharkhand, Bihar, and West Bengal: 2.872 Neutral Publishing House Ltd. 19 Bartaman: Bengali: West Bengal, Odisha, Jharkhand, Bihar, Delhi, Mumbai and other cities in India 2.750 Bartaman Pvt ...
The residents of Nicoya, Costa Rica—known for its coastal views south of the Nicaraguan border—have routinely enjoyed three foods together for at least 6,000 years old, Dan Buettner, the Blue ...
In 2004–5, the Indian biotech industry saw its revenues grow 37% to $1.1 billion. The Indian biotech market is dominated by biopharmaceuticals; 76% of 2004–5 revenues came from biopharmaceuticals, which saw 30% growth last year. Of the revenues from biopharmaceuticals, vaccines led the way, comprising 47% of sales.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. [ 10 ] The company's key focus areas include paediatrics , cardiovascular , anti-infectives , diabetology , asthma and anti-tuberculosis .
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. [4] It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals , paper , construction , textiles , nutrition and animal health industries. [ 5 ]
Concord Biotech was founded in 2000 by Sudhir Vaid, a former director at Ranbaxy Laboratories. [4] It was the first company in India and the second in the world to develop an anti-immuno suppressant tacrolimus. [7] In 2004, Rakesh Jhunjhunwala acquired around 14% stake in the company.